MK, G., P, D., MC, C., JA, B., SA, H., V, S., . . . S, B. (2026). Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis. Inflammatory bowel diseases, 32(7), 1344. https://doi.org/10.1093/ibd/izag042
Chicago Style (17th ed.) CitationMK, Goyal, et al. "Rethinking the Dose: A Bayesian Meta-analysis of Infliximab Intensification in Acute Severe Ulcerative Colitis." Inflammatory Bowel Diseases 32, no. 7 (2026): 1344. https://doi.org/10.1093/ibd/izag042.
MLA (9th ed.) CitationMK, Goyal, et al. "Rethinking the Dose: A Bayesian Meta-analysis of Infliximab Intensification in Acute Severe Ulcerative Colitis." Inflammatory Bowel Diseases, vol. 32, no. 7, 2026, p. 1344, https://doi.org/10.1093/ibd/izag042.
Warning: These citations may not always be 100% accurate.
